首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Technical study of the leucocyte migration inhibition test in agarose. Application to PPD and to hepatitis B antigen
【2h】

Technical study of the leucocyte migration inhibition test in agarose. Application to PPD and to hepatitis B antigen

机译:琼脂糖中白细胞迁移抑制试验的技术研究。在PPD和乙型肝炎抗原中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A modification of the leucocyte migration inhibition test, in which cells migrate in an agarose layer, was proposed by Clausen (1971). In the present study, this method was applied to PPD and hepatitis B antigen (HBAg), and its advantages were reassessed.From a technical standpoint, the migration in a monolayer facilitated a study of the morphology of the migrating cells. The proportion of the different kinds of migrating leucocytes was calculated and expressed as a function of the distance of migration. On the whole, 92% of the migrating leucocytes were polymorphonuclears and 8% lymphomonocytes. Three to 10% of the incubated cells were shown to migrate in the agarose layer. The surface area of the controls (migration without inhibition) was sufficiently constant and large (on the average 13 mm2) to allow a clear assessment of inhibition when antigen was added. In addition, the small requirement for antigen facilitated the use of this test in experimentation with purified HBAg.Application of the technique to clinical problems revealed that, with PPD as antigen, a highly significant inhibition was obtained in PPD skin test-positive normal individuals (0·0025<P<0·005). But this inhibition was not significant (0·05<P<0·1) in PPD skin test-positive patients during the course of acute hepatitis B. With HBAg as antigen, a significant inhibition was obtained in individuals having recovered from acute hepatitis B. Such an inhibition was not demonstrable in individuals without a history of hepatitis, nor in patients during the course of the disease.These results demonstrate the suitability of the leucocyte migration inhibition test in agarose for routine detection of cell-mediated immunity in man. They further suggest the development of cell-mediated immunity specific for HBAg after recovery from acute hepatitis B and impairment of this type of immune response to PPD during the acute phase of hepatitis.
机译:Clausen(1971)提出了对白细胞迁移抑制试验的一种改进,其中细胞在琼脂糖层中迁移。本研究将这种方法应用于PPD和乙型肝炎抗原(HBAg),并重新评估了其优势。从技术角度看,单层迁移促进了迁移细胞形态的研究。计算了不同种类的迁移白细胞的比例,并将其表示为迁移距离的函数。总体而言,迁移的白细胞中有92%是多形核细胞,而8%是淋巴细胞。已显示三到10%的温育细胞在琼脂糖层中迁移。对照的表面积(没有抑制的迁移)足够恒定且足够大(平均13 mm 2 ),可以清楚地评估添加抗原时的抑制率。此外,对抗原的少量需求促进了该试验在纯化HBAg实验中的应用。该技术在临床问题中的应用表明,以PPD为抗原,对PPD皮肤试验阳性的正常个体具有高度显着的抑制作用( 0·0025

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号